Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald J Buchsbaum

Showing results (41-50 of 157) with videos related to

Pageof 16
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2004
Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancerSergey A Kaliberov, Lyudmila N Kaliberova, Cecil R Stockard, et al.
Journal of Cellular Biochemistry|April 18, 2018
Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cellsRomone M Fancy, Harrison Kim, Tiara Napier, et al.
Cancer|March 6, 2002
Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vectorBuck E Rogers, Kurt R Zinn, Chin-Yu Lin, et al.
Clinical and Translational Medicine|March 3, 2017
Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifsGeorge E Naoum, Zeng B Zhu, Donald J Buchsbaum, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 8, 2011
The use of retinoids in ovarian cancer: a review of the literatureJenny M Whitworth, J Michael Straughn, Venkatram R Atigadda, et al.
Molecular Cancer Research : MCR|March 2, 2011
Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cellsHope M Amm, Tong Zhou, Adam D Steg, et al.
Gynecologic Oncology|May 14, 2016
Ovarian cancer and the immune system - The role of targeted therapiesTaylor B Turner, Donald J Buchsbaum, J Michael Straughn, et al.
Journal of Visualized Experiments : Jove|May 5, 2015
Dynamic contrast enhanced magnetic resonance imaging of an orthotopic pancreatic cancer mouse modelHyunki Kim, Sharon Samuel, John W Totenhagen, et al.
Gynecologic Oncology|July 3, 2007
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its therapeutic potential in breast and gynecologic cancersJames E Kendrick, Jacob M Estes, J Michael Straughn, et al.
Pancreas|January 20, 2012
A deimmunized bispecific ligand-directed toxin that shows an impressive anti-pancreatic cancer effect in a systemic nude mouse orthotopic modelSeunguk Oh, Deborah A Todhunter, Angela Panoskaltsis-Mortari, et al.
Pageof 16

Showing results (41-50 of 157) with videos related to

Sort By:
Pageof 16
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2004
Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancerSergey A Kaliberov, Lyudmila N Kaliberova, Cecil R Stockard, et al.
Journal of Cellular Biochemistry|April 18, 2018
Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cellsRomone M Fancy, Harrison Kim, Tiara Napier, et al.
Cancer|March 6, 2002
Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vectorBuck E Rogers, Kurt R Zinn, Chin-Yu Lin, et al.
Clinical and Translational Medicine|March 3, 2017
Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifsGeorge E Naoum, Zeng B Zhu, Donald J Buchsbaum, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 8, 2011
The use of retinoids in ovarian cancer: a review of the literatureJenny M Whitworth, J Michael Straughn, Venkatram R Atigadda, et al.
Molecular Cancer Research : MCR|March 2, 2011
Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cellsHope M Amm, Tong Zhou, Adam D Steg, et al.
Gynecologic Oncology|May 14, 2016
Ovarian cancer and the immune system - The role of targeted therapiesTaylor B Turner, Donald J Buchsbaum, J Michael Straughn, et al.
Journal of Visualized Experiments : Jove|May 5, 2015
Dynamic contrast enhanced magnetic resonance imaging of an orthotopic pancreatic cancer mouse modelHyunki Kim, Sharon Samuel, John W Totenhagen, et al.
Gynecologic Oncology|July 3, 2007
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its therapeutic potential in breast and gynecologic cancersJames E Kendrick, Jacob M Estes, J Michael Straughn, et al.
Pancreas|January 20, 2012
A deimmunized bispecific ligand-directed toxin that shows an impressive anti-pancreatic cancer effect in a systemic nude mouse orthotopic modelSeunguk Oh, Deborah A Todhunter, Angela Panoskaltsis-Mortari, et al.
Pageof 16